| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/17/2001 | WO2001034844A1 Method for isolating dna from a proteinaceous medium and kit for performing method |
| 05/17/2001 | WO2001034842A2 Pcr amplification on microarrays of gel immobilized oligonucleotides |
| 05/17/2001 | WO2001034841A1 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME 18q RELATED DISORDERS |
| 05/17/2001 | WO2001034840A2 Genetic compositions and methods |
| 05/17/2001 | WO2001034839A1 Approaches to identify genetic traits |
| 05/17/2001 | WO2001034838A1 Method of detecting variation or polymorphism |
| 05/17/2001 | WO2001034837A1 Diagnosis and prognosis of cancer through detection of the tumor antigen 17-1a by rt-pcr |
| 05/17/2001 | WO2001034836A2 Susceptibility locus for osteoarthritis |
| 05/17/2001 | WO2001034835A2 Method for the production of biopolymers with modified properties |
| 05/17/2001 | WO2001034833A2 Regulating endogenous inhibitor at atp synthase |
| 05/17/2001 | WO2001034832A2 Assays using redox-enzymes immobilised n hydrophilic polymers |
| 05/17/2001 | WO2001034831A2 Determination of catalase activity |
| 05/17/2001 | WO2001034830A2 Assay of micro-organisms in cell cultures |
| 05/17/2001 | WO2001034827A1 Antisense modulation of rank expression |
| 05/17/2001 | WO2001034824A2 Methods and compositions comprising renilla gfp |
| 05/17/2001 | WO2001034806A2 Methods and compositions for screening using diphtheria toxin constructs |
| 05/17/2001 | WO2001034805A2 Human vanilloid receptor gene |
| 05/17/2001 | WO2001034802A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/17/2001 | WO2001034794A1 Casb7434, an antigen over-expressed in colon cancer |
| 05/17/2001 | WO2001034793A1 Method of effecting dna splicing |
| 05/17/2001 | WO2001034790A1 Method for synthesizing nucleic acid |
| 05/17/2001 | WO2001034789A2 Computational method for inferring elements of gene regulatory network from temporal patterns of gene expression |
| 05/17/2001 | WO2001034773A2 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME 18q RELATED DISORDERS |
| 05/17/2001 | WO2001034772A2 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME 18q RELATED DISORDERS |
| 05/17/2001 | WO2001034771A2 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME 18q RELATED DISORDERS |
| 05/17/2001 | WO2001034767A2 22 human secreted proteins |
| 05/17/2001 | WO2001034765A1 Methods and apparatus for the electronic, homogeneous assembly and fabrication of devices |
| 05/17/2001 | WO2001034653A2 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 05/17/2001 | WO2001034652A1 Antibodies to suberic acid crosslinkers and methods for using the same |
| 05/17/2001 | WO2001034644A1 15 human secreted proteins |
| 05/17/2001 | WO2001034643A1 24 human secreted proteins |
| 05/17/2001 | WO2001034640A2 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 05/17/2001 | WO2001034636A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/17/2001 | WO2001034634A2 Tumor suppressor molecules and methods of use |
| 05/17/2001 | WO2001034629A1 21 human secreted proteins |
| 05/17/2001 | WO2001034628A1 35 human secreted proteins |
| 05/17/2001 | WO2001034627A1 28 human secreted proteins |
| 05/17/2001 | WO2001034626A1 28 human secreted proteins |
| 05/17/2001 | WO2001034624A1 Methods for identifying compounds that affect rna/rna binding protein interactions |
| 05/17/2001 | WO2001034623A1 29 human secreted proteins |
| 05/17/2001 | WO2001034621A1 Kringle domain-containing polynucleotides, polypeptides, and antibodies |
| 05/17/2001 | WO2001034302A2 Biochannel assay for hybridization with biomaterial |
| 05/17/2001 | WO2001034201A2 Methods for inhibiting neurofibromatosis type 1 (nf1) |
| 05/17/2001 | WO2001034167A1 Isolation and expansion of human marrow stromal cells |
| 05/17/2001 | WO2001033956A1 Melanocortin-4 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 05/17/2001 | WO2001033954A1 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 05/17/2001 | WO2001028995A8 Drug target isogenes: polymorphisms in the cholinergic receptor, muscarinic 5 gene |
| 05/17/2001 | WO2001021635A3 Method for electrochemically detecting sequence-specific nucleic acid-oligomer hybridisation events |
| 05/17/2001 | WO2001020003A3 Variants of the gamma chain of ampk, dna sequences encoding the same, and uses thereof |
| 05/17/2001 | WO2001018233A3 Screening for inhibitors of lumazine synthase |
| 05/17/2001 | WO2001012598A9 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 05/17/2001 | WO2001007646A3 Method for quantization of the antiviral effect of antiviral active principles |
| 05/17/2001 | WO2001007607A3 FULL LENGTH cDNA CLONES AND PROTEINS ENCODED THEREBY |
| 05/17/2001 | WO2001007471A9 Cell cycle and proliferation proteins |
| 05/17/2001 | WO2001002593A3 Control of gene expression in eukaryotic cells |
| 05/17/2001 | WO2000077166A3 Gene expression modulated in gastrointestinal inflammation |
| 05/17/2001 | WO2000075377A3 Non-cognate hybridization system (nchs) |
| 05/17/2001 | WO2000075368A3 Method for the synthesis of dna fragments |
| 05/17/2001 | WO2000075306A3 Method for producing double stranded polynucleotides |
| 05/17/2001 | WO2000071710A3 Expression products of genes involved in diseases related to cholesterol metabolism |
| 05/17/2001 | WO2000068414A3 Whole cell assay for cathepsin k |
| 05/17/2001 | WO2000043551A9 Determining viral load in double negative t cells |
| 05/17/2001 | WO2000030671A9 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto |
| 05/17/2001 | WO1999038972A9 Human genes and gene expression products ii |
| 05/17/2001 | US20010001290 Methods for enhancing the production of viral vaccines in cell culture |
| 05/17/2001 | DE19952568A1 Determining binding constants for ligand-target complexes, useful e.g. for determining concentration of small molecules, uses fluorescently labeled nucleic acid ligands |
| 05/17/2001 | CA2428827A1 Human vanilloid receptor gene |
| 05/17/2001 | CA2396626A1 Methods and compositions for screening using diphtheria toxin constructs |
| 05/17/2001 | CA2391369A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/17/2001 | CA2391366A1 Computational method for inferring elements of gene regulatory network from temporal patterns of gene expression |
| 05/17/2001 | CA2391362A1 Serotype-specific identification of enterovirus 71 by rt-pcr |
| 05/17/2001 | CA2391009A1 Biosensing using surface plasmon resonance |
| 05/17/2001 | CA2391004A1 Method for quantitating oligonucleotides |
| 05/17/2001 | CA2390740A1 Melanocortin-4 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 05/17/2001 | CA2390723A1 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 05/17/2001 | CA2390646A1 Compositions and methods for regulating endogenous inhibitor of atp synthase, including treatment for diabetes |
| 05/17/2001 | CA2390421A1 24 human secreted proteins |
| 05/17/2001 | CA2390374A1 Diagnosis and treatment of malignant neoplasms |
| 05/17/2001 | CA2390144A1 Assay of micro-organisms in cell cultures |
| 05/17/2001 | CA2390011A1 Methods and compositions comprising renilla gfp |
| 05/17/2001 | CA2389724A1 28 human secreted proteins |
| 05/17/2001 | CA2389550A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/17/2001 | CA2389549A1 Biochannel assay for hybridization with biomaterial |
| 05/17/2001 | CA2389488A1 Isolation and expansion of human marrow stromal cells |
| 05/17/2001 | CA2389330A1 Kringle domain-containing polynucleotides, polypeptides, and antibodies |
| 05/17/2001 | CA2389326A1 35 human secreted proteins |
| 05/17/2001 | CA2389305A1 28 human secreted proteins |
| 05/17/2001 | CA2389204A1 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 05/17/2001 | CA2388914A1 15 human secreted proteins |
| 05/17/2001 | CA2388343A1 Methods for inhibiting neurofibromatosis type 1 (nf1) |
| 05/17/2001 | CA2388034A1 Direct mapping of dna chips to detector arrays |
| 05/17/2001 | CA2388008A1 29 human secreted proteins |
| 05/17/2001 | CA2387964A1 22 human secreted proteins |
| 05/17/2001 | CA2387959A1 21 human secreted proteins |
| 05/17/2001 | CA2386866A1 Tumor suppressor molecules and methods of use |
| 05/17/2001 | CA2382348A1 Methods for identifying compounds that affect rna/rna binding protein interactions |
| 05/17/2001 | CA2359955A1 Human vanilloid receptor gene |
| 05/17/2001 | CA2325226A1 Use of polypeptides or nucleic acids encoding these for the diagnosis or treatment of skin disorders, and their use for the identification of pharmacologically active substances |
| 05/16/2001 | EP1099765A1 Quantitative determination method of mannose and reagent therefor |
| 05/16/2001 | EP1099764A2 Sterilization indicator using DNA specific dyes |